Marshall Clement D, Hu Michael S, Leavitt Tripp, Barnes Leandra A, Lorenz H Peter, Longaker Michael T
Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, California.
Adv Wound Care (New Rochelle). 2018 Feb 1;7(2):29-45. doi: 10.1089/wound.2016.0696.
Scarring of the skin from burns, surgery, and injury constitutes a major burden on the healthcare system. Patients affected by major scars, particularly children, suffer from long-term functional and psychological problems. Scarring in humans is the end result of the wound healing process, which has evolved to rapidly repair injuries. Wound healing and scar formation are well described on the cellular and molecular levels, but truly effective molecular or cell-based antiscarring treatments still do not exist. Recent discoveries have clarified the role of skin stem cells and fibroblasts in the regeneration of injuries and formation of scar. It will be important to show that new advances in the stem cell and fibroblast biology of scarring can be translated into therapies that prevent and reduce scarring in humans without major side effects. Novel therapies involving the use of purified human cells as well as agents that target specific cells and modulate the immune response to injury are currently undergoing testing. In the basic science realm, researchers continue to refine our understanding of the role that particular cell types play in the development of scar.
烧伤、手术及外伤导致的皮肤瘢痕给医疗系统带来了沉重负担。受严重瘢痕影响的患者,尤其是儿童,会长期面临功能和心理问题。人类瘢痕形成是伤口愈合过程的最终结果,而伤口愈合过程是为快速修复损伤而进化而来的。在细胞和分子层面,伤口愈合和瘢痕形成已得到充分描述,但真正有效的基于分子或细胞的抗瘢痕治疗方法仍然不存在。最近的研究发现阐明了皮肤干细胞和成纤维细胞在损伤修复和瘢痕形成中的作用。证明瘢痕形成的干细胞和成纤维细胞生物学方面的新进展能够转化为在无重大副作用的情况下预防和减少人类瘢痕形成的疗法,这一点至关重要。目前,涉及使用纯化人类细胞以及靶向特定细胞并调节对损伤的免疫反应的新型疗法正在进行测试。在基础科学领域,研究人员不断深化我们对特定细胞类型在瘢痕形成中所起作用的理解。